Table 3.
St Type | Nanocarrier | Preparation | Physicochemical and Release Properties | Ref. | |||
---|---|---|---|---|---|---|---|
Particle Size (nm) | Zeta Potential (mV) | Encapsulation Efficiency (%) | In vitro Release | ||||
Endogenous stimuli-responsive En-St-Mc-SDDS | |||||||
pH | Eph A10/TPP-DTX liposomes | Thin-flm hydration method | 131.5 ± 2.6 | −16.25 ± 0.38 | 74.7 ± 1.7 | pH 5.0: ~80% | [42] |
pH 7.4: ~30% | |||||||
CTPP-CSOSA/celastrol micelles | Dialysis method | 63.5 ± 18.0 | 22.1 ± 0.3 | 92.3 ± 0.7 | pH 5.0: ~0 | [43] | |
pH 7.4: ~40% | |||||||
pH 8.0: ~90% | |||||||
HER-2/DOX DQAsomes | Thin-flm hydration method | 112.7 ± 3.3 | 12.7 ± 2.8 | 53.4 ± 3.8 | pH 5.0: 73.5% | [36] | |
pH 7.4: 53.2% | |||||||
PEG-AIE-TPP micelle | Solvent evaporation method | ~130.0 | – | – | pH 5.3: ~90% | [44] | |
pH 6.5: ~40% | |||||||
pH 7.4: ~30% | |||||||
HPMA-MSN/DTX nanoparticles | Stirring-centrifugation method | 190.4 ± 4.9 | −18.2 | 8.34 (LC) | pH 5.0: 4.2 mV (1 h) | [45] | |
pH 6.5: 4.2 mV (2 h) | |||||||
pH 7.4: −16.4 mV | |||||||
PEG-TPP-Que nanoparticles | Dialysis method | 93.5 ± 0.1 | 23.6 ± 1.5 | – | – | [46] | |
DSPE-KLA-DMA/PTX liposomes | Thin-film hydration method | 155.3 ± 2.2 | ~-15.0 | 81.8 ± 0.7 | pH 4.5: 35.0 mV | [47] | |
pH 5.5: 25.0 mV | |||||||
pH 6.8: 10.0 mV | |||||||
pH 7.4: ~-15.0 mV | |||||||
PDPA/TPGS/DOX micelles | Thin-film hydration method | 57.3 ± 3.4 | – | ~70 | pH 5.5: ~70% | [48] | |
pH 7.4: ~35% | |||||||
HHG2C18 liposomes | Film dispersion method | – | −22.9 | 96.75 (Temsirolimus) 93.76 (Coumarin 6) |
pH 4.5: 25.5 mV | [49] | |
pH 5.5: 15.3 mV | |||||||
pH 6.5: 6.3 mV | |||||||
pH 7.4: −22.9 mV | |||||||
Redox | TPP-oHA-S-S-Cur micelles | Dialysis method | 122.4 ± 23.4 | −26.55 ± 4.99 | – | 0 µM GSH: 32.5% | [50] |
10 µM GSH: 37% | |||||||
2 mM GSH: 57.5% | |||||||
10 mM GSH: 75.3% | |||||||
PLGA/C18-PEG-TPP/DLPE-S-S-mPEG/PTX nanoparticles | Singlestep nanoprecipitation strategy | 178.6 ± 1.2 | 2.4 ± 0.8 | 8.3 ± 0.1 (LC) | 10 µM GSH: 2.4 mV | [51] | |
10 mM GSH: 17.2 mV | |||||||
Enzyme | HA/PEG/berberine derivative nanodrugs | nano-precipitation method | 151.2 ± 2.7 | −25.8 ± 1.4 | 70.1 ± 2.3 | HAase/pH 4.5: 13.47 mV | [19] |
HAase/pH 5.6: 10.39 mV | |||||||
HAase/pH 7.4: slightly negative potential | |||||||
Non-isocyanate polyurethane-TPP/DOX nanocapsule | Inverse miniemulsion process | 250~260 | – | 91~94 | Esterase: 93-fold higher at emission intensity | [52] | |
TPP-peptide nanoassemblies | Self-assembly method | L-1P: 121 | – | – | ALP: 635 nm (L-1P) | [53] | |
ALP: 196 nm (D-1P) | |||||||
D-1P: 58 | |||||||
Peptide/DNA complexes | Self-assembly method | 130~480 | −3~-35 | – | – | [37] | |
Exogenous stimuli-responsive Ex-St-Mc-SDDS | |||||||
Light | Perfluorooctyl bromide/IR780 liposomes | One-step emulsion strategy | 268.3 | – | 92.5 | Laser exposure: keep 56% of the largest absorbance when IR780 is photobleached | [54] |
Iridium/Fe3O4 nanozyme | Magnet precipitated and separated method | ~8 | – | – | Temperature increment due to laser and iridium | [55] | |
IR-780/DSPE-PEG2K-TPP liposomes | Film-hydration and sonication method | 125.0 ± 63.4 | 23.5 ± 3.1 | 83.6 | 37 °C: 34.1% | [56] | |
43 °C: 74.9% | |||||||
NIR: 78.2% | |||||||
mPEG-CHO-PAIE-TPP nanoparticles | Synthetic method | ~200 | 2.96 ± 0.2 | – | pH 5.4: hydrolysis | [57] | |
pH 6.8: hydrolysis | |||||||
pH 7.4: mPEG-CHO is undetectable | |||||||
AuNS-KLA-TPP/HA/DOX nanoparticles | Stirring-centrifugation method | 94.6 | −13.1 | – | pH 6.8 + HAase + NIR: 75% | [58] | |
TPP/Ce6/PEG-/FA-PEG-Pt@Au nanoparticles | Ultrasound-stirring-centrifugation method | 21.5 | −42 | – | – | [59] | |
Au-dcHSA-PEO-TAT-TPP nanoparticles | Synthetic method | 85.2 | 10.67 | – | Stable in phosphate buffer, glucose, NaCl, pH 3.9, pH 10 and protease/trypsin solutions | [60] | |
PPa-NGO-mAb nanodrug | Synthetic method | 100~400 | – | – | Stable in water, PBS, DMEM, serum and different pH solutions | [64] | |
Yb/Tm/TiO2 nanoparticles | Thermal decomposition reaction | ~100 | – | – | – | [65] | |
TPP-coumarin-Fe3O4 nanoparticles | Synthetic method | ~15 | – | – | – | [66] | |
Cyt c aptamer-mesoporous silica-Au nanorods | Synthetic method | ~20 | – | 7.3 (LC) | NIR (no): 5% | [67] | |
NIR (first time): 17% | |||||||
NIR (second time): 7% | |||||||
SWNT-PEG nanotubes | Synthetic method | – | – | – | – | [68] | |
Magnetic field | DNA/PK-CP-SPION complexes | Grignard reagent reaction method | 49.7 | 32.7 | – | – | [69,79] |
Fe3O4@mSiO2-TPP/CDs nanoparticles | Liquid-solid-solid synthetic route | 82.30 | 16.33 | – | – | [70] | |
AMB-1-Cyt c aptamer bacterial magnetic nanoparticles | Originating from Magnetospirillum sp. AMB-1 | 50 | – | – | – | [71,80] | |
Multi-responsive St-Mc-SDDS | |||||||
pH/light | Catalase@SiO2/Ce6-CTPP/DPEG nanoparticles | Synthetic method | ~100 | −18 | – | Protease K: 70% (remained activity) | [20] |
Fe3O4@DMSA/DOX nanoparticles | Synthetic method | 102.02 ± 0.6 | – | >90 | pH 5.0: 80.3% | [72] | |
pH 7.4: 19.2% | |||||||
pH 5.0+NIR: 98.5% | |||||||
pH 7.4+NIR: 30.0% | |||||||
Redox/light/magnetic field | DOX/Fe3O4/TPP-PDA-s-s-mPEG nanoparticles | Synthetic method | 165 | 4 | 41 (LC) | pH 7.4+ GSH: 18 mV | [73] |
pH 5.0: ~35% | |||||||
pH 7.4: ~15% | |||||||
pH 5.0+NIR: ~65% | |||||||
pH 7.4+NIR: ~40% | |||||||
Magnetic field/light | Fe3O4@PDA@mSiO2-TPP/-PEG nanoparticles | Synthetic method | 275 | −5.2 | – | – | [74] |
pH/redox/temperature | MBA-PDA-PEG-PNiPMA/Pc 4 nanogel | Synthetic method | 108.1 ± 11.1 | −5.62 ± 1.40 | – | pH 7.4: 108 nm, 13.6% | [75] |
pH 5.0: 360 nm, 30.3% | |||||||
DTT/EDTA: 1200 nm | |||||||
Temperature>39 °C: particle size: increase | |||||||
Redox/light | TPP-PPA micelles | Modified oil-in-water emulsion-based self-assembly method | 176.3 ± 12.3 | – | 3.1 ± 0.2 (LC) | Low ROS: 30 μg/cm2 | [76] |
High ROS: 50 μg/cm2 | |||||||
Redox/enzyme | Glucose-PEG-peptide-TPP-PAMAM-PTX conjugates | Synthetic method | 42.5 ± 18.4 | 2.9 ± 1.1 | – | 0 µM GSH: 26% | [78] |
10 µM GSH: 52% | |||||||
10 mM GSH: 79% |
Notes: The bold texts refer to the Mc-targeting components in St-Mc-DDSs. These components include an Mc group or an Mc molecule (lipophilic cation, peptide or aptamer), and a material. Abbreviation: LC, loading capacity.